Intravenous immunoglobulin for cystic fibrosis lung disease: A case series of 16 children

Archives of Disease in Childhood

Volumn 89, Issue 4, 2004, Pages 315-319

  Balfour Lynn, I M ^a   Mohan, U ^a   Bush, A ^a   Rosenthal, M ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BUDESONIDE; CORTICOSTEROID; IMMUNOGLOBULIN; ITRACONAZOLE; PREDNISOLONE;

ADOLESCENT; ASEPTIC MENINGITIS; CHEST TIGHTNESS; CHILD; CONFIDENCE INTERVAL; COUGHING; CYSTIC FIBROSIS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; HYPOTENSION; LUNG DISEASE; MALE; MYDRIASIS; NAUSEA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SYMPTOM; THORAX DISEASE; TREATMENT OUTCOME; VOMITING; WHEEZING;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PREDNISOLONE; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VITAL CAPACITY;

EID: 1942534010     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.026575     Document Type: Review

References (21)

1. Balfour-Lynn IM, Elborn JS. CF asthma: what is it and what do we do about it? Thorax 2002;57:742-8.
2. Davies J, Rosenthal M, Bush A. Severe small airways disease resistant to medical treatment in a child with cystic fibrosis. J R Soc Med 1996;89:172P-3P.
3. Mazer BD, Gelfand EW. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 1991;87:976-83.
4. Mastella G, Rainisio M, Harms HK, et al, on behalf of the investigators of the Epidemiologic Registry of Cystic Fibrosis. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Resp J 2000;16:464-71.
5. Marchant JL, Warner JO, Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 1994;49:1002-5.
6. Brown K, Rosenthal M, Bush A. Fatal invasive aspergillosis in an adolescent with cystic fibrosis. Pediatr Pulmonol 1999;27:130-3.
7. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-55.
8. Vrugt B, Wilson S, van Velzen E, et al. Effects of high dose intravenous immunoglobulin in two severe corticosteroid insensitive asthmatic children. Thorax 1997;52:662-4.
9. Sylvester I, Yoshimura T, Sticherling M, et al. Neutrophil attractant protein-1 - immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest 1992;90:471-81.
10. Winnie GB, Cowan RG, Wade NA. Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis. J Pediatr 1989;114:309-14.
11. Fick RB Jr, Naegel GP, Squier SU, et al. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J Clin Invest 1984;74:236-48.
12. Van Wye JE, Collins MS, Baylor M, et al. Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 1990;9:7-18.
13. Jakobsson T, Croner S, Kjellman NI, et al. Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. Allergy 1994;49:413-20.
14. Spahn JD, Leung DYM, Chan MTS, et al. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 1999;103:421-6.
15. Niggemann B, Leupold W, Schuster A, et al. Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma. Clin Exp Allergy 1998;28:205-10.
16. Salmun LM, Barlan I, Wolf HM, et al. Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 1999;103:810-15.
17. Kishiyama JL, Valacer D, Cunningham-Rundles C, et al. A multicenter, randomised, double-blind, placebo-controlled trial of intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol 1999;91:126-33.
18. Sigman K, Ghibu F, Sommerville W, et al. Intravenous immunoglobulin inhibits IgE production in human B lymphocytes. J Allergy Clin Immunol 1998;102:421-427.
19. Cheng K, Ashby D, Smyth R. Oral steroids for cystic fibrosis (Cochrane Review). In: The Cochrane Library, issue 1. Oxford: Update Software, 2002.
20. Chapel HM. Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissible agents. Clin Exp Immunol 1999;118(Suppl 1):29-34.
21. Jaffé A, Balfour-Lynn IM. Treatment of severe small airways disease in children with cystic fibrosis: Alternatives to corticosteroids. Paediatr Drugs 2002;4:381-9.